# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-094885
Filing Date
2021-07-22
Accepted
2021-07-22 16:00:55
Documents
4
Period of Report
2021-09-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2122609-1_def14a.htm | DEF 14A | 573825
2 | GRAPHIC | lg_replimune-4c.jpg | GRAPHIC | 46353
3 | GRAPHIC | tm2122609d-px_pg01proxybw.jpg | GRAPHIC | 789354
4 | GRAPHIC | tm2122609d-px_pg02proxybw.jpg | GRAPHIC | 1016139
| Complete submission text file | 0001104659-21-094885.txt |  | 3121210

Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-38596 | Film No.: 211107596
SIC: 2836 Biological Products, (No Diagnostic Substances)